Why Bausch Health Companies Inc. (BHC) Went Up On Thursday?

We recently published a list of 10 Firms Stand Out Amid Market Downturn. In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against other firms that stand out amid market downturn.

Pessimistic sentiment persisted on the stock market on Thursday as investors moved to sell off shares in an effort to minimize risks from uncertainties brought about by President Donald Trump’s continued tariff threats and policy shifts.

The Dow Jones plunged 1.01 percent, the S&P 500 declined 0.43 percent, and the tech-heavy Nasdaq lost 0.47 percent.

Amidst the overall market downturn, 10 companies stood out, clocking in double-digit gains during the trading session, thanks to a flurry of positive catalysts including strong corporate earnings results.

To come up with Thursday’s top performers, we considered only the stocks with $2 billion in market capitalization and $5 million in daily trading volume.

A series of pharmaceutical and medical products in a warehouse, displaying the range of products available.

Bausch Health Companies Inc (NYSE:BHC)

Bausch Health Companies Inc. (NYSE:BHC) saw its share prices rise by 10 percent on Thursday, a third consecutive day, to close at $7.18 apiece as investors cheered news of its strong earnings performance last year coupled with a bullish outlook this year.

In a statement, BHC said it achieved a 5.9-percent rise in net income attributable to the company of $430 million for the fourth quarter of 2024 from the $406 million registered in the same period in 2023, as revenue grew 6 percent to $2.559 billion from $2.408 billion year-on-year.

For the full year 2024, BHC narrowed its net losses by 92 percent to $46 million from $592 million in 2023, as revenues increased 9 percent to $9.625 billion from $8.757 billion year-on-year.

For this year, BHC expects revenues to settle anywhere between $9.9 billion to $10.15 billion—an outlook that was more bullish than the average analyst estimate of $9.95 billion.

Overall, BHC ranks 10th on our list of firms that stand out amid market downturn. While we acknowledge the potential of BHC as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than BHC but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.